Company intelligence / Profile preview

SUN bioscience

Lausanne, Vaud, Switzerlandsunbioscience.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

SUN bioscience has developed and commercialized the Gri3D® high-throughput microwell plate system that enables robust and scalable generation of standardized organoids from patient-derived or pluripotent stem cells. Their technology addresses key challenges in reproducibility and scalability of organoid cultures. The company collaborates with academic institutions globally but does not itself conduct clinical trials or develop therapeutic drugs directly. Their products are used as advanced preclinical models for drug discovery and personalized medicine applications.

Modalities
Organoid-based in vitro models (using stem cells)Device (high-throughput microwell platform)Hydrogel-based drug delivery therapy (platform for organoid culture)
Industry
Non-Drug Biotech
02

Partnerships

Academic collaborations with University of Edinburgh MRC Center of Regenerative MedicineInstitute of Molecular and Clinical Ophthalmology BaselDanish Stem Cell Center CopenhagenUtrecht University

Beyond the preview

Go deeper on SUN bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUN bioscience.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call